These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 19861516)
1. Variation in the FGFR2 gene and the effects of postmenopausal hormone therapy on invasive breast cancer. Prentice RL; Huang Y; Hinds DA; Peters U; Pettinger M; Cox DR; Beilharz E; Chlebowski RT; Rossouw JE; Caan B; Ballinger DG Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3079-85. PubMed ID: 19861516 [TBL] [Abstract][Full Text] [Related]
2. Breast cancer susceptibility associated with rs1219648 (fibroblast growth factor receptor 2) and postmenopausal hormone therapy use in a population-based United States study. Andersen SW; Trentham-Dietz A; Figueroa JD; Titus LJ; Cai Q; Long J; Hampton JM; Egan KM; Newcomb PA Menopause; 2013 Mar; 20(3):354-8. PubMed ID: 23435034 [TBL] [Abstract][Full Text] [Related]
3. Variation in the FGFR2 gene and the effect of a low-fat dietary pattern on invasive breast cancer. Prentice RL; Huang Y; Hinds DA; Peters U; Cox DR; Beilharz E; Chlebowski RT; Rossouw JE; Caan B; Ballinger DG Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):74-9. PubMed ID: 20056625 [TBL] [Abstract][Full Text] [Related]
4. FGFR2 intronic polymorphisms interact with reproductive risk factors of breast cancer: results of a case control study in Japan. Kawase T; Matsuo K; Suzuki T; Hiraki A; Watanabe M; Iwata H; Tanaka H; Tajima K Int J Cancer; 2009 Oct; 125(8):1946-52. PubMed ID: 19582883 [TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in second intron of the FGFR2 gene are associated with the risk of early-onset breast cancer in Chinese Han women. Fu F; Wang C; Huang M; Song C; Lin S; Huang H Tohoku J Exp Med; 2012 Mar; 226(3):221-9. PubMed ID: 22374580 [TBL] [Abstract][Full Text] [Related]
6. Associations of polymorphisms in the genes of FGFR2, FGF1, and RBFOX2 with breast cancer risk by estrogen/progesterone receptor status. Cen YL; Qi ML; Li HG; Su Y; Chen LJ; Lin Y; Chen WQ; Xie XM; Tang LY; Ren ZF Mol Carcinog; 2013 Nov; 52 Suppl 1():E52-9. PubMed ID: 23143756 [TBL] [Abstract][Full Text] [Related]
7. Association of polymorphisms in intron 2 of FGFR2 and breast cancer risk in Сhinese women. Pan Z; Bao Y; Zheng X; Cao W; Cheng W; Xu X Tsitol Genet; 2016; 50(5):59-64. PubMed ID: 30480917 [TBL] [Abstract][Full Text] [Related]
8. The association of polymorphisms in hormone metabolism pathway genes, menopausal hormone therapy, and breast cancer risk: a nested case-control study in the California Teachers Study cohort. Lee E; Schumacher F; Lewinger JP; Neuhausen SL; Anton-Culver H; Horn-Ross PL; Henderson KD; Ziogas A; Van Den Berg D; Bernstein L; Ursin G Breast Cancer Res; 2011 Apr; 13(2):R37. PubMed ID: 21457551 [TBL] [Abstract][Full Text] [Related]
9. Relation of FGFR2 genetic polymorphisms to the association between oral contraceptive use and the risk of breast cancer in Chinese women. Xu WH; Shu XO; Long J; Lu W; Cai Q; Zheng Y; Xiang YB; Dai Q; Zhao GM; Gu K; Bao PP; Gao YT; Zheng W Am J Epidemiol; 2011 Apr; 173(8):923-31. PubMed ID: 21382839 [TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in the BRCA1 and ABCB1 genes modulate menopausal hormone therapy associated breast cancer risk in postmenopausal women. MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk Breast Cancer Res Treat; 2010 Apr; 120(3):727-36. PubMed ID: 19672706 [TBL] [Abstract][Full Text] [Related]
11. Genetic variants in fibroblast growth factor receptor 2 (FGFR2) contribute to susceptibility of breast cancer in Chinese women. Liang J; Chen P; Hu Z; Zhou X; Chen L; Li M; Wang Y; Tang J; Wang H; Shen H Carcinogenesis; 2008 Dec; 29(12):2341-6. PubMed ID: 18845558 [TBL] [Abstract][Full Text] [Related]
12. Functional analysis of a breast cancer-associated FGFR2 single nucleotide polymorphism using zinc finger mediated genome editing. Robbez-Masson LJ; Bödör C; Jones JL; Hurst HC; Fitzgibbon J; Hart IR; Grose RP PLoS One; 2013; 8(11):e78839. PubMed ID: 24265722 [TBL] [Abstract][Full Text] [Related]
13. Estrogen plus progestin and breast cancer incidence and mortality in the Women's Health Initiative Observational Study. Chlebowski RT; Manson JE; Anderson GL; Cauley JA; Aragaki AK; Stefanick ML; Lane DS; Johnson KC; Wactawski-Wende J; Chen C; Qi L; Yasmeen S; Newcomb PA; Prentice RL J Natl Cancer Inst; 2013 Apr; 105(8):526-35. PubMed ID: 23543779 [TBL] [Abstract][Full Text] [Related]
14. A genome-wide association study to identify genetic susceptibility loci that modify ductal and lobular postmenopausal breast cancer risk associated with menopausal hormone therapy use: a two-stage design with replication. Hein R; Flesch-Janys D; Dahmen N; Beckmann L; Lindström S; Schoof N; Czene K; Mittelstraß K; Illig T; Seibold P; Behrens S; Humphreys K; Li J; Liu J; Olson JE; Wang X; Hankinson SE; Truong T; Menegaux F; Dos Santos Silva I; Johnson N; ; Chen ST; Yu JC; Ziogas A; Kataja V; Kosma VM; Mannermaa A; Anton-Culver H; Shen CY; Brauch H; Peto J; Guénel P; Kraft P; Couch FJ; Easton DF; Hall P; Chang-Claude J Breast Cancer Res Treat; 2013 Apr; 138(2):529-542. PubMed ID: 23423446 [TBL] [Abstract][Full Text] [Related]
15. A study on genetic variants of Fibroblast growth factor receptor 2 (FGFR2) and the risk of breast cancer from North India. Siddiqui S; Chattopadhyay S; Akhtar MS; Najm MZ; Deo SV; Shukla NK; Husain SA PLoS One; 2014; 9(10):e110426. PubMed ID: 25333473 [TBL] [Abstract][Full Text] [Related]
16. Genetic variants of fibroblast growth factor receptor 2 (FGFR2) are associated with breast cancer risk in Chinese women of the Han nationality. Chen F; Lu M; Xue Y; Zhou J; Hu F; Chen X; Zhao Z; Li Y; Wang X Immunogenetics; 2012 Jan; 64(1):71-6. PubMed ID: 21822685 [TBL] [Abstract][Full Text] [Related]
17. TNRC9 rs12443621 and FGFR2 rs2981582 polymorphisms and breast cancer risk. Chen Y; Shi C; Guo Q World J Surg Oncol; 2016 Feb; 14(1):50. PubMed ID: 26911390 [TBL] [Abstract][Full Text] [Related]
18. Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium. Campa D; Kaaks R; Le Marchand L; Haiman CA; Travis RC; Berg CD; Buring JE; Chanock SJ; Diver WR; Dostal L; Fournier A; Hankinson SE; Henderson BE; Hoover RN; Isaacs C; Johansson M; Kolonel LN; Kraft P; Lee IM; McCarty CA; Overvad K; Panico S; Peeters PH; Riboli E; Sanchez MJ; Schumacher FR; Skeie G; Stram DO; Thun MJ; Trichopoulos D; Zhang S; Ziegler RG; Hunter DJ; Lindström S; Canzian F J Natl Cancer Inst; 2011 Aug; 103(16):1252-63. PubMed ID: 21791674 [TBL] [Abstract][Full Text] [Related]
19. Hormone-dependent effects of FGFR2 and MAP3K1 in breast cancer susceptibility in a population-based sample of post-menopausal African-American and European-American women. Rebbeck TR; DeMichele A; Tran TV; Panossian S; Bunin GR; Troxel AB; Strom BL Carcinogenesis; 2009 Feb; 30(2):269-74. PubMed ID: 19028704 [TBL] [Abstract][Full Text] [Related]
20. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. Colditz GA; Hankinson SE; Hunter DJ; Willett WC; Manson JE; Stampfer MJ; Hennekens C; Rosner B; Speizer FE N Engl J Med; 1995 Jun; 332(24):1589-93. PubMed ID: 7753136 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]